Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney disease

Autor: Fabrizio Fabrizi, Sami Aoufi-Rabih, Manuel Mendizabal, Rebeca García-Agudo, Ezequiel Ridruejo, Marcelo Silva, Vivek Dixit
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Nefrología (English Edition), Vol 40, Iss 1, Pp 46-52 (2020)
Nefrología, Vol 40, Iss 1, Pp 46-52 (2020)
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
ISSN: 2013-2514
Popis: BACKGROUND AND AIMS:The advent of direct-acting antiviral agents promises to change the management of hepatitis C virus infection (HCV) in patients with chronic kidney disease (CKD), a patient group in which the treatment of hepatitis C was historically challenging. We investigated the safety and efficacy of all-oral, interferon-free direct-acting antiviral agents for the treatment of hepatitis C in a 'real-world' cohort of patients with CKD.METHODS:We performed an observational single-arm multi-centre study in a large (n=198) cohort of patients with stage 1-3 CKD who underwent antiviral therapy with DAAs for the treatment of HCV. The primary end-point was sustained virologic response (serum HCV RNA
Databáze: OpenAIRE